Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Regulation of Appetite and Obesity, and Genetic factors in colorectal cancer.
ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic Cancer.
Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment.
Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview
Contribution of genetics to hematopoietic stem cell mobilization: a genomewide association study of 564 healthy donors mobilized with granulocyte colony-stimulating factor
Differentiating Main-Duct IPMN from Chronic Pancreatitis Using Next-Generation Sequencing of Main Pancreatic Duct Fluid: A Pilot Study.
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
First proficiency testing for <scp>NGS</scp>‐based and combined <scp>NGS</scp>‐ and <scp>FISH</scp>‐based detection of <scp><i>FGFR2</i></scp> fusions in intrahepatic cholangiocarcinoma
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
[Structure and content of the EU-IVDR : Current status and implications for pathology].
Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer.
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma.
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
Knowledge bases and software support for variant interpretation in precision oncology
<scp>KRAS</scp>/<scp>GNAS</scp>‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreas
Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
Targeting rare and non-canonical driver variants in NSCLC – An uncharted clinical field
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma
Knowledge bases and software support for variant interpretation in precision oncology.
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival